摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,2-二(4-乙氧基苯基)-1,1,1-三氯乙烷 | 4329-03-7

中文名称
2,2-二(4-乙氧基苯基)-1,1,1-三氯乙烷
中文别名
——
英文名称
1,1-bis(4-ethoxyphenyl)-2,2,2-trichloroethane
英文别名
2,2-bis-(4-ethoxy-phenyl)-1,1,1-trichloro-ethane;2,2-Bis-(4-aethoxy-phenyl)-1,1,1-trichlor-aethan;β.β.β-Trichlor-α.α-bis-(4-aethoxy-phenyl)-aethan;1,1,1-Trichlor-2,2-di-(p-ethoxy-phenyl)-ethan;Ethoxychlor;1-ethoxy-4-[2,2,2-trichloro-1-(4-ethoxyphenyl)ethyl]benzene
2,2-二(4-乙氧基苯基)-1,1,1-三氯乙烷化学式
CAS
4329-03-7
化学式
C18H19Cl3O2
mdl
MFCD00018838
分子量
373.707
InChiKey
RMWNXWAWVFPXNO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.8
  • 重原子数:
    23
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    18.5
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2909309090

SDS

SDS:68aeb38c4e95b3e05f7d9369836de046
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2,2-二(4-乙氧基苯基)-1,1,1-三氯乙烷氢氧化钾sodium ethanolate 作用下, 生成 1,2-bis(4-ethoxyphenyl)ethyne
    参考文献:
    名称:
    The Influence of Growth Hormone Deficiency, Growth Hormone Replacement Therapy, and Other Aspects of Hypopituitarism on Fracture Rate and Bone Mineral Density
    摘要:
    为了评估影响成年垂体功能减退症患者骨折风险和骨密度的因素,特别是生长激素缺乏症(GHD)的影响,我们分析了一项大规模药物流行病学调查(法玛西亚与安万特国际代谢数据库[KIMS])的数据,并与对照人群(欧洲椎骨骨质疏松症研究[EVOS])的数据进行了比较。KIMS组包括2084名患者(1112名男性和972名女性),他们患有各种类型的垂体疾病,而EVOS组包括1176名个体(581名男性和595名女性)。从KIMS组的2024名患者和EVOS组的392名患者中获得了骨折和骨矿物质密度(BMD)数据。垂体功能减退症患者的骨折发生率是GH非缺乏的EVOS人群的2.66倍。与儿童期发病的疾病相比,成年期发病的垂体功能减退症伴GHD与更高的骨折风险相关,而孤立性GHD患者的骨折发生率与多重垂体激素缺乏症患者的骨折发生率相似。使用L-甲状腺素、糖皮质激素和性激素的激素替代疗法并未影响KIMS患者的骨折风险。此外,KIMS中的骨折率与体重指数(BMI)和原籍国无关。然而,吸烟与该组较高的骨折率相关。总之,这是首次大规模分析支持成年垂体功能减退症和GHD患者骨折风险增加的假设。这种增加的风险似乎仅归因于GHD,而非其他垂体激素缺乏或其替代疗法。
    DOI:
    10.1359/jbmr.2001.16.2.398
  • 作为产物:
    参考文献:
    名称:
    The Influence of Growth Hormone Deficiency, Growth Hormone Replacement Therapy, and Other Aspects of Hypopituitarism on Fracture Rate and Bone Mineral Density
    摘要:
    为了评估影响成年垂体功能减退症患者骨折风险和骨密度的因素,特别是生长激素缺乏症(GHD)的影响,我们分析了一项大规模药物流行病学调查(法玛西亚与安万特国际代谢数据库[KIMS])的数据,并与对照人群(欧洲椎骨骨质疏松症研究[EVOS])的数据进行了比较。KIMS组包括2084名患者(1112名男性和972名女性),他们患有各种类型的垂体疾病,而EVOS组包括1176名个体(581名男性和595名女性)。从KIMS组的2024名患者和EVOS组的392名患者中获得了骨折和骨矿物质密度(BMD)数据。垂体功能减退症患者的骨折发生率是GH非缺乏的EVOS人群的2.66倍。与儿童期发病的疾病相比,成年期发病的垂体功能减退症伴GHD与更高的骨折风险相关,而孤立性GHD患者的骨折发生率与多重垂体激素缺乏症患者的骨折发生率相似。使用L-甲状腺素、糖皮质激素和性激素的激素替代疗法并未影响KIMS患者的骨折风险。此外,KIMS中的骨折率与体重指数(BMI)和原籍国无关。然而,吸烟与该组较高的骨折率相关。总之,这是首次大规模分析支持成年垂体功能减退症和GHD患者骨折风险增加的假设。这种增加的风险似乎仅归因于GHD,而非其他垂体激素缺乏或其替代疗法。
    DOI:
    10.1359/jbmr.2001.16.2.398
点击查看最新优质反应信息

文献信息

  • Baghos,V.B. et al., Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1977, vol. 15B, p. 368 - 371
    作者:Baghos,V.B. et al.
    DOI:——
    日期:——
  • Localised enamel hypoplasia of human deciduous canines: genotype or environment?
    作者:Sue Taji、Toby Hughes、Jim Rogers、Grant Townsend
    DOI:10.1111/j.1834-7819.2000.tb00246.x
    日期:2000.6
    AbstractA discrete area of defective enamel formation that appears on the labial surface of the crowns of deciduous canine teeth has been described in both recent and prehistoric human population, with reported frequencies varying from 1 to 45 per cent. Suggestions about the aetiology of this localized hypoplasia range from genotypic factors to environmental conditions and systemic effects. The major aims of this study were to describe the frequency of occurrence and pattern of expression of the lesion in Australian Aboriginal and Caucasian ethnic groups, and to clarify the role of genetic factors by examining a sample of twins.The study sample consisted of dental casts of 181 pairs of Australian Caucasian twins, 215 Aborigines and 122 Caucasian singletons, together with 253 extracted deciduous canines. Examination of dental casts and extracted teeth was undertaken under 2X magnification with emphasis being placed upon location and expression of the lesion.The defect was observed in 49 per cent of twins and 44 per cent of Aborigines, but only 36 per cent of singletons. The percentages of affected teeth in each group were: 18 per cent in twins, 17 per cent in Aborigines and 13 per cent in Caucasians. A significant proportion of the defects occurred on the mesial aspect of the labial surface, in the middle area incisocervically, with the majority in the lower jaw. Anumber of significant differences in frequency were observed between groups, sexes, arches and sides.The results confirm some of the findings of previous studies, but also suggest that none of environmental, genetic or systemic factors can be ruled out as being involved in aetiology of the defect. The higher incidence of the lesion occurring on the mesial aspect of the labial surface is suggestive of physical trauma. Also, the vulnerability of the prominent developing mandibular canine, with its thin or missing labial covering of bone, would be expected to lead to higher prevalence of the lesion in the lower jaw. Although not definitive, the results of concordance analyses in twins were suggestive of a possible genetic predisposition in the formation of the lesion. Further research with a greater clinical orientation and emphasis on determing specific aetiological factors within any given environment in different ethnic groups may provide better insight into the ambiguous aetiology of the hypoplastic enamel defect.
  • Baghos,V.B. et al., Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1977, vol. 15B, p. 364 - 367
    作者:Baghos,V.B. et al.
    DOI:——
    日期:——
  • Brand, Chemische Berichte, 1913, vol. 46, p. 2939
    作者:Brand
    DOI:——
    日期:——
  • Brand; Horn, Journal fur praktische Chemie (Leipzig 1954), 1927, vol. <2> 115, p. 359
    作者:Brand、Horn
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐